COGENT BIOSCIENCES
Cogent Biosciences uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body’s own immune system to fight cancer. Unum’s lead program, based on its Antibody-Coupled T-cell Receptor (ACTR) technology, is expected to enter Phase I clinical testing in the coming months to assess safety and efficacy. Unum is seeking partners interested in using the ACTR technology to arm proprietary tumor-specific antibodies with a T-cell to improve their therapeutic potential. The company is headquartered in Cambridge, Massachusetts.
COGENT BIOSCIENCES
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2014-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.cogentbio.com
Total Employee:
101+
Status:
Active
Contact:
(617) 843-5032
Total Funding:
432.7 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail IPv6 ReCAPTCHA GoDaddy DNS ReCAPTCHA V2 AWS Global Accelerator
Similar Organizations
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Urovant Sciences
Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.
Current Advisors List
Board_member
2020-07-06
Board_member
2014-01-01
Board_member
2018-02-01
Board_member
2020-07-06
Board_member
2018-03-01
Board_member
Board_member
2016-02-01
Board_member
2014-09-01
Current Employees Featured
Jessica Sachs Chief Medical Officer @ Cogent Biosciences
Chief Medical Officer
2019-07-01
Charles Wilson President and CEO @ Cogent Biosciences
President and CEO
2014-03-01
Dario Campana Scientific Founders @ Cogent Biosciences
Scientific Founders
Geoffrey Hodge SVP Operations @ Cogent Biosciences
SVP Operations
2015-06-01
Matthew Osborne CFO @ Cogent Biosciences
CFO
2019-06-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-07-06 | Kiq | Kiq acquired by Cogent Biosciences | N/A |
Investors List
Logos Capital
Logos Capital investment in Post-IPO Equity - Cogent Biosciences
Commodore Capital
Commodore Capital investment in Post-IPO Equity - Cogent Biosciences
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Post-IPO Equity - Cogent Biosciences
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Cogent Biosciences
RTW Investments LLC
RTW Investments LLC investment in Post-IPO Equity - Cogent Biosciences
Samsara BioCapital
Samsara BioCapital investment in Post-IPO Equity - Cogent Biosciences
Atlas Venture
Atlas Venture investment in Post-IPO Equity - Cogent Biosciences
OrbiMed
OrbiMed investment in Post-IPO Equity - Cogent Biosciences
Ally Bridge Group
Ally Bridge Group investment in Post-IPO Equity - Cogent Biosciences
BVF Partners
BVF Partners investment in Post-IPO Equity - Cogent Biosciences
Official Site Inspections
http://www.cogentbio.com Semrush global rank: 4.99 M Semrush visits lastest month: 1.69 K
- Host name: 44.255.196.104.bc.googleusercontent.com
- IP address: 104.196.255.44
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Cogent Biosciences"
About – Cogent Biosciences
Throughout his career in biotech he has managed the strategic build out of numerous finance teams aligning people, processes and systems to the strategic goals of the organization. This …See details»
Cogent Biosciences - Crunchbase Company Profile & Funding
Contact Email info@cogentbio.com Phone Number +1 617 843 5032 Cogent Biosciences uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to …See details»
Overview | Cogent Biosciences, Inc.
Nov 20, 2024 The Investor Relations website contains information about Cogent Biosciences, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Cogent Biosciences Company Profile | Management and
SQL International Organization for Standardization . HTML Web Hypertext Application Technology Working Group . PHP PHP . CSS World Wide Web Consortium . Team …See details»
Cogent Biosciences - Company Profile & Staff Directory
Cogent Biosciences is a biotechnology company developing real solutions to treat genetically driven diseases. With a focus on rational drug discovery and development, we are leveraging …See details»
COGENT BIOSCIENCES, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for COGENT BIOSCIENCES, INC. of Boulder, CO. Get the latest business insights from Dun & Bradstreet.See details»
Cogent Biosciences - Overview, News & Similar companies
Cogent Biosciences contact info: Phone number: (617) 945-5576 Website: www.cogentbio.com What does Cogent Biosciences do? Cogent Biosciences, Inc., a biotechnology company, …See details»
Cogent Biosciences Company Overview, Contact Details
Feb 13, 2024 Cogentbio is developing portfolio of novel targeted therapies to help patients fighting serious, genetically driven diseases initially targeting mutations in FGFR2, ErbB2 and …See details»
Cogent Biosciences - Craft
Net income (Q2, 2024)($59.0M) Cash (Q1, 2024)$215.8M EBIT (Q2, 2024)($64.4M) Enterprise value $869.0MSee details»
Cogent Biosciences - LinkedIn
Cogent Biosciences is a biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs.See details»
Cogent Biosciences Company Profile: Overview and Full News …
Cogentbio.com. Life Sciences. Overview: Cogent Biosciences. ... They have established a world-class discovery organization in Boulder, Colorado, specializing in creating best-in-class small …See details»
Cogent Biosciences Information - RocketReach
Cogent Biosciences is a biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs.See details»
Cogent Biosciences, Inc.
Government, non-profit or academic organization of high standing. • The nominee shall be highly accomplished in his or her respective field, with superior credentials and recognition. • The …See details»
Cogent Biosciences - Company Profile - Tracxn
Dec 2, 2024 Cogent Biosciences is a developer of precision therapy for treating diseases like cancer, rare diseases, autoimmune conditions & others. The company is developing solutions …See details»
Cogent Biosciences, Inc. - Drug pipelines, Patents, Clinical
Visit our website for more information at www.cogentbio.com. Follow Cogent Biosciences on social media: X (formerly known as Twitter) and LinkedIn. ... he was the Chief Medical Officer …See details»
Cogent Biosciences Announces Participation at Upcoming Investor ...
Feb 1, 2023 Visit our website for more information at www.cogentbio.com. Follow Cogent Biosciences on social media: Twitter and LinkedIn. Information that may be important to …See details»
Cogent Biosciences Announces Creation of Cogent Research Team
Apr 14, 2021 Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the …See details»
Cogent Biosciences Announces Presentation at the 43rd Annual J.P ...
7 hours ago christi.waarich@cogentbio.com 617-830-1653. Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. SHARE THIS POST. …See details»
Pipelines & Targets – Cogent Biosciences
Cole is an accomplished executive with extensive commercial development, new product launch, P&L, and strategic leadership experience over a 20 plus year career in the pharmaceutical …See details»
Cogent Biosciences Announces Presentation at the 43rd Annual J.P ...
8 hours ago WALTHAM, Mass. and BOULDER, Colo., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing …See details»